Here are relevant reports on : tissue-paper-market
-
Agricultural Testing Market by Sample (Soil, Water, Seed, Compost, Manure, Biosolids, Plant Tissue), Application (Saftey Testing, Quality Assurance), Technology (Conventional, Rapid) and Region ( North America, Europe, APAC, Row) - Global Forecast to 2028
According to MarketsandMarkets, the agricultural testing market is projected to reach USD 9.8 billion by 2028, at a CAGR of 7.1% during the forecast period. This report includes a study of the marketing and development strategies, along with the product portfolio of leading companies. These companies include SGS (Switzerland), Eurofins (Luxembourg), Intertek (UK), Bureau Veritas (France), ALS Limited (Australia), TUV Nord Group (Germany), Merieux (US), AsureQuality (New Zealand), RJ Hill Laboratories Limited (New Zealand), SCS Global (US), Agrifood Technology (Australia), APAL Agricultural Laboratory (Australia), Agvise Laboratories (US), LGC Limited (UK) and Water Agricultural Laboratories (US)
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022
The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the orthobiologics market. The major players in the market are DePuy Synthes, Medtronic, Stryker, Zimmer Biomet, Harvest Technologies, Globus Medical, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, Bioventus, NuVasive, SeaSpine, Arthrex, and Xtant Medical.
- Published: September 2017
- Price: $ 4950
- TOC Available:
-
Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030
The global biosurgery market, valued at US$14.96 billion in 2024, stood at US$15.83 billion in 2025 and is projected to advance at a resilient CAGR of 6.4% from 2025 to 2030, culminating in a forecasted valuation of US$21.59 billion by the end of the period. Some of the prominent players operating in the market include market Medtronic (Ireland), Johnson & Johnson Services, Inc. (US), Baxter (US), Becton, Dickinson and Company (BD) (US), B. Braun SE (Germany), Stryker (US), Integra Lifesciences Holdings Corporation (US), CSL Ltd. (Australia), Hemostasis LLC (US), and Pfizer Inc. (US), among others.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019
The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.
- Published: September 2014
- Price: $ 4950
- TOC Available:
-
Anatomic Pathology Track and Trace Solutions Market by Product (Software, Hardware (Printer & Labeling Systems), Consumables), Technology (Barcode, RFID), Application (Tissue Cassette, Slide Tracking), End User (Hospital Labs) - Global Forecast to 2023
The global anatomic pathology track and trace solutions market is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4%. The increasing volume of diagnostic tests performed in anatomic pathology laboratories, rising number of legal cases around cancer misdiagnosis, benefits of automated labeling solutions, increasing consolidation among anatomic pathology laboratories, and the growing adoption of automated systems to enhance the efficiency of laboratories are the major factors driving the growth of this market. However, the high cost associated with the implementation of track and trace solutions in anatomic pathology laboratories is expected to restrain the growth of this market during the forecast period. The key players operating in the global anatomic pathology track and trace solutions market are Thermo Fisher Scientific (US), Leica Biosystems (Germany), General Data Healthcare (US), Ventana Medical Systems (US), Agilent Technologies (US), Sunquest Information Systems (US), Zebra Technologies Corporation (US), Primera Technology (US), Cerebrum Corporation (US), AP Easy Software Solutions (US), and LigoLab (US).
- Published: October 2018
- Price: $ 4950
- TOC Available:
-
Cell Culture Equipment Market by Type (Supporting, Bioreactors, Storage), Application (Biopharma Production, Diagnostics, Tissue Engineering), End User (Pharma & Biotech Companies, Hospitals & Diagnostic Labs, Academia), Region - Global Forecast to 2031
The Cell Culture Equipment market, valued at USD 7.77 billion in 2025, stood at USD 8.36 billion in 2026 and is projected to advance at a resilient CAGR of 11.1% from 2026 to 2031, culminating in a forecasted valuation of USD 14.18 billion by the end of the period. Cell culture equipment encompasses the instruments used to grow and maintain cells in controlled laboratory environments for medical, research, and production purposes.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Surgical Instruments Market by Product (Sutures, Foreceps, Scissors, Electrosurgery Instruments, Cannulas), Animal (Canines, Felines, Large Animals), Application (Soft tissue, Sterilization, Gynecology, Orthopedic Surgery)- Global Forecast to 2021
The global veterinary surgical instruments market size is projected to grow at a CAGR of 6.6%. The increasing demand for veterinary surgical instruments is driven by the rising companion animal population coupled with the growing demand for pet insurance, the rising animal health awareness levels along with the increasing animal healthcare expenditure.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Prosthetic Heart Valve Market by Type (Transcatheter Heart Valve, Tissue Heart Valve, and Mechanical Heart Valve), and Region (North America, Europe, Asia-Pacific, and RoW) - Global Forecast to 2022
The prosthetic heart valves market is growing at a CAGR of 12.9%. Some of the prominent players in the market are Medtronic plc (Ireland), Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (an Abbott Laboratories Company) (U.S.), LivaNova PLC (U.K.), Symetis SA (Switzerland), Jenavalve Technology, Inc. (Germany), CryoLife, Inc. (U.S.), TTK Healthcare Limited (India), Colibri Heart Valve, LLC (U.S.), Lepu Medical Technology Co., Ltd. (China), and Braile Biomédica (Brazil) are the prominent players in the global prosthetic heart valves market.
- Published: June 2017
- Price: $ 4950
- TOC Available:
-
Orthopedic Biomaterials Market by Type (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, Natural Biomaterials), Application (Joint Replacement, Spine Surgery, Bioresorbable Tissue Fixation, Orthobiologics, & Fracture Fixation) - Forecast to 2030
The orthopedic biomaterials market, valued at US$15.74 billion in 2024, stood at US$16.95 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$24.86 billion by the end of the period. This market encompasses load-bearing implants, bone cements, bioresorbable fixation devices, injectable viscoelastic gels, regenerative scaffolds, and specialized design-related services.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Biocompatible 3D Printing Materials Market by Type (Polymer, Metal), Application (Implants & Prosthesis, Prototyping & Surgical Guides, Tissue Engineering, Hearing Aid), Form (Powder, Liquid), and Region - Global Forecast to 2023
The biocompatible 3D printing materials market size is estimated to be USD 308.1 million in 2018 and is projected to reach USD 832.7 million by 2023, at a CAGR of 22.0% between 2018 and 2023. This growth is attributed to the increasing use of biocompatible 3D printing materials in medical applications such as implants & prosthesis, tissue engineering, and hearing aid among others.3D Systems, Inc. (US), Evonik Industries AG (Germany), Stratasys Ltd. (US), Concept Laser, GmBH (Germany), EOS GmBH Electro Optical Systems (Germany), Renishaw PLC. (UK), Formlabs Inc. (US), EnvisionTEC, Inc. (Germany), 3D Composites (US), and Aspect Biosystems Ltd. (Canada) are the key players operating in the biocompatible 3D printing materials market.
- Published: September 2018
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
